SCHEMBL17613340

SCHEMBL17613340

CC(C)(C)OC(=O)c1cccc(-c2cc(Br)c(N)c3ccccc23)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC7A5 Q01650 1/20 0.42
▸ ABCG2 Q9UNQ0 2/20 0.41
▸ ABCB1 P08183 1/20 0.41
▸ HKDC1 Q2TB90 1/20 0.40
▸ CA12 O43570 2/20 0.39
▸ CA1 P00915 2/20 0.39
▸ CA2 P00918 2/20 0.39
▸ CA9 Q16790 2/20 0.39
▸ CA14 Q9ULX7 1/20 0.39
▸ STAT3 P40763 1/20 0.38
▸ GRM6 O15303 1/20 0.38
▸ BRD4 O60885 1/20 0.36
▸ AXL P30530 1/20 0.36
▸ ASH1L Q9NR48 1/20 0.35
▸ CTSB P07858 1/20 0.35
▸ GABRA1 P14867 3/20 0.35
▸ GABRG2 P18507 3/20 0.35
▸ GABRB3 P28472 3/20 0.35
▸ GABRA3 P34903 3/20 0.35
▸ GABRA2 P47869 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599394 0.86 CA12 (0.50) HKDC1CA12CA1CA2CA9
SCHEMBL17599344 0.81 ABCG2 (0.45) SLC7A5ABCG2ABCB1CA12CA1
SCHEMBL8362720 0.79 SLC7A5 (0.47) SLC7A5ABCG2ABCB1CA12CA1
SCHEMBL17599410 0.76 ABCG2 (0.35) SLC7A5ABCG2ABCB1CA12CA1
SCHEMBL1410040 0.75 KMO (0.55) SLC7A5ABCG2ABCB1CA12CA1
SCHEMBL2344130 0.75 SLC7A5 (0.52) SLC7A5CA12CA1CA2CA9
SCHEMBL17599409 0.75 MEN1 (0.38) SLC7A5ABCG2ABCB1CA12CA1
SCHEMBL8097492 0.73 CA12 (0.49) SLC7A5CA12CA1CA2CA9
SCHEMBL31188294 0.73 CA12 (0.49) SLC7A5CA12CA1CA2CA9
SCHEMBL2580296 0.73 PPARG (0.45) ABCG2ABCB1BRD4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback